The North America Recombinant Proteins Market should witness market growth of 10.3% CAGR during the forecast period (2022-2028).
Today, a range of recombinant proteins, such as those utilised in medical therapies, are produced using various bioprocessing processes. In the recombinant protein market, worldwide, for instance, vaccinations are produced using recombinant DNA technology to help prevent the spread of illnesses. It can also be utilized to make pharmaceuticals and other healthcare products. Utilizing recombinant protein has numerous advantages. One benefit is that recombinant protein products are more precise and reliable than those produced using conventional techniques.
In September 2020, GigaGen Inc. began mass manufacture of its first-in-class recombinant hyperimmune medication GIGA-2050 for the treatment of COVID-19 in association with Waisman Biomanufacturing and Goodwin Biotechnology Inc.
Due to rising research spending, a developed healthcare system, and a number of significant market players, North America is predicted to lead the recombinant protein market. Recombinant proteins are one of the tried-and-true treatments for the chronic diseases that are becoming more prevalent throughout the region, which is driving up demand for recombinant protein therapies. Effective therapies are required due to the rising incidence of cancer.
The US market dominated the North America Recombinant Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $708.8 million by 2028. The Canada market is poised to grow at a CAGR of 12.8% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 11.8% during (2022-2028).
Based on Product, the market is segmented into Growth Factors & Chemokines, Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors, Structural Proteins, Membrane Proteins, Kinase Proteins & Regulatory Proteins, Immune Response Proteins, and Others. Based on End-user, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research Studies, Biopharmaceutical Production, Diagnostics, Biotechnology Research, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.
Today, a range of recombinant proteins, such as those utilised in medical therapies, are produced using various bioprocessing processes. In the recombinant protein market, worldwide, for instance, vaccinations are produced using recombinant DNA technology to help prevent the spread of illnesses. It can also be utilized to make pharmaceuticals and other healthcare products. Utilizing recombinant protein has numerous advantages. One benefit is that recombinant protein products are more precise and reliable than those produced using conventional techniques.
In September 2020, GigaGen Inc. began mass manufacture of its first-in-class recombinant hyperimmune medication GIGA-2050 for the treatment of COVID-19 in association with Waisman Biomanufacturing and Goodwin Biotechnology Inc.
Due to rising research spending, a developed healthcare system, and a number of significant market players, North America is predicted to lead the recombinant protein market. Recombinant proteins are one of the tried-and-true treatments for the chronic diseases that are becoming more prevalent throughout the region, which is driving up demand for recombinant protein therapies. Effective therapies are required due to the rising incidence of cancer.
The US market dominated the North America Recombinant Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $708.8 million by 2028. The Canada market is poised to grow at a CAGR of 12.8% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 11.8% during (2022-2028).
Based on Product, the market is segmented into Growth Factors & Chemokines, Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors, Structural Proteins, Membrane Proteins, Kinase Proteins & Regulatory Proteins, Immune Response Proteins, and Others. Based on End-user, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research Studies, Biopharmaceutical Production, Diagnostics, Biotechnology Research, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.
Scope of the Study
By Product
- Growth Factors & Chemokines
- Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors
- Structural Proteins
- Membrane Proteins
- Kinase Proteins & Regulatory Proteins
- Immune Response Proteins
- Others
By End-user
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Others
By Application
- Drug Discovery & Development
- Academic Research Studies
- Biopharmaceutical Production
- Diagnostics
- Biotechnology Research
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Bio-Techne Corporation
- Thermo Fisher Scientific, Inc.
- Merck Group
- Bio-Rad Laboratories, Inc.
- Abcam plc
- Genscript Biotech Corporation
- Miltenyi Biotec B.V. & Co. KG
- Proteintech Group, Inc.
- BPS Bioscience, Inc.
- RayBiotech Life, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Recombinant Proteins Market, by Product
1.4.2 North America Recombinant Proteins Market, by End User
1.4.3 North America Recombinant Proteins Market, by Application
1.4.4 North America Recombinant Proteins Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Recombinant Proteins Market
Chapter 4. North America Recombinant Proteins Market by Product
4.1 North America Growth Factors & Chemokines Market by Country
4.2 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
4.3 North America Structural Proteins Market by Country
4.4 North America Membrane Proteins Market by Country
4.5 North America Kinase Proteins & Regulatory Proteins Market by Country
4.6 North America Immune Response Proteins Market by Country
4.7 North America Others Market by Country
Chapter 5. North America Recombinant Proteins Market by End User
5.1 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
5.2 North America Biotechnology Companies Market by Country
5.3 North America Academic Research Institutes Market by Country
5.4 North America Contract Research Organizations Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Recombinant Proteins Market by Application
6.1 North America Drug Discovery & Development Market by Country
6.2 North America Academic Research Studies Market by Country
6.3 North America Biopharmaceutical Production Market by Country
6.4 North America Diagnostics Market by Country
6.5 North America Biotechnology Research Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Recombinant Proteins Market by Country
7.1 US Recombinant Proteins Market
7.1.1 US Recombinant Proteins Market by Product
7.1.2 US Recombinant Proteins Market by End User
7.1.3 US Recombinant Proteins Market by Application
7.2 Canada Recombinant Proteins Market
7.2.1 Canada Recombinant Proteins Market by Product
7.2.2 Canada Recombinant Proteins Market by End User
7.2.3 Canada Recombinant Proteins Market by Application
7.3 Mexico Recombinant Proteins Market
7.3.1 Mexico Recombinant Proteins Market by Product
7.3.2 Mexico Recombinant Proteins Market by End User
7.3.3 Mexico Recombinant Proteins Market by Application
7.4 Rest of North America Recombinant Proteins Market
7.4.1 Rest of North America Recombinant Proteins Market by Product
7.4.2 Rest of North America Recombinant Proteins Market by End User
7.4.3 Rest of North America Recombinant Proteins Market by Application
Chapter 8. Company Profiles
8.1 Bio-Techne Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Abcam plc
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Genscript Biotech Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expenses
8.7 Miltenyi Biotech B.V. & Co. KG
8.7.1 Company Overview
8.8 Proteintech Group, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 BPS Bioscience, Inc.
8.9.1 Company Overview
8.10. RayBiotech Life, Inc.
8.10.1 Company Overview
Companies Mentioned
- Bio-Techne Corporation
- Thermo Fisher Scientific, Inc.
- Merck Group
- Bio-Rad Laboratories, Inc.
- Abcam plc
- Genscript Biotech Corporation
- Miltenyi Biotec B.V. & Co. KG
- Proteintech Group, Inc.
- BPS Bioscience, Inc.
- RayBiotech Life, Inc.
Methodology
LOADING...
